151 – 160 of 216
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2000
-
Mark
Prognostic factors for the course of β cell function in autoimmune diabetes
(
- Contribution to journal › Article
-
Mark
Newly diagnosed latent autoimmune diabetes in adults (LADA) is associated with low level glutamate decarboxylase (GAD65) and IA-2 autoantibodies
(
- Contribution to journal › Article
-
Mark
Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes
(
- Contribution to journal › Article
-
Mark
Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds
(
- Contribution to journal › Article
-
Mark
Evaluation of a novel radioimmunoassay using 125I-labelled human recombinant GAD65 for the determination of glutamic acid decarboxylase (GAD65) autoantibodies
(
- Contribution to journal › Article
- 1999
-
Mark
Prevalence of β-cell and Thyroid Autoantibody Positivity in Schoolchildren during Three-Year Follow-up
(
- Contribution to journal › Article
-
Mark
Previous exposure to measles, mumps, and rubella--but not vaccination during adolescence--correlates to the prevalence of pancreatic and thyroid autoantibodies.
(
- Contribution to journal › Article
-
Mark
Species-specific autoantibodies in type 1 diabetes
(
- Contribution to journal › Article
-
Mark
Appearance of islet cell autoantibodies after clinical diagnosis of diabetes mellitus
(
- Contribution to journal › Article
-
Mark
Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment : A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes
(
- Contribution to journal › Article